India: Prices of 869 Formulations to Go up by Over 3%
Prices of 869 formulations, including antibiotics, cancer and cardiovascular disease treatment drugs and two types of coronary stents, have gone up by 3.44%, according to the National Pharmaceutical Pricing Authority (NPPA).
The NPPA is mandated to fix/revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country. It also monitors the prices of decontrolled drugs in order to keep them at reasonable levels.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
China Wholesale High Quality Weight Loss Retatrutide Peptide Vials 5mg 10mg CAS 2381089-83-2 Safe Delivery and Fast
$130/UNIT FOB
2026-07-07
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
in-cosmetics Global reveals line-up for 2026 programme curated for innovation
-
Agri Technology Asia(2024) will be held in Lahore from July 27-29
-
Prospects for plant protection mergers and acquisitions in Central America and Mexico
-
Bayer Australia is officially certified and 60 products are produced locally
-
The 24th ACE will be held in Shanghai in November
-
An important layout in the overseas market, Zhongxun (Thailand)Agri-Science officially opened
-
The bird repellent market has great growth potential and is expected to reach $420 million by 2028
-
Huaxing’s Spinosad formulation products obtained U.S. OMRI certification
-
In the past 5 years, 102 pesticide products have been registered for cotton in China, with more PGR
-
The annual output of 5,000 tons of Penoxsulam and Glufosinate-ammonium project’s environmental assessment was published
Recommend Reading
-
Aficamten Beats Metoprolol in Obstructive HCM, Strengthening Case Ahead of FDA Decision
-
AstraZeneca Targets Year-End Filing for Novel Hypertension Drug Baxdrostat
-
FDA Clears Sanofi’s Wayrilz (rilzabrutinib) for Adult ITP; U.S. Launch in September
-
West Asia’s Conflict Is Testing the Hidden Fragility of Pharma Trade
-
China’s Approval of Pfizer’s GLP-1 Drug Signals a Sharper Obesity Race
-
EFSA Deems Extended Use of Bacillolysin Enzyme Safe
-
EFSA Finds Lavender Tincture Feed Additive Safe for All Animals
-
EU Alerts on Non-Compliant Chinese Oyster Sauce and Miso Exports
-
Formic Acid Moving Averages Set to Cross Upward—Rising Trend May Be About to Begin
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function